Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T23:26:39.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new revision entry, v3.7.0, was added to the study record history and the prior revision, v3.6.6, was removed, reflecting an updated version of the record in the history trail.
    Difference
    0.1%
    Check dated 2026-09-19T22:21:02.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' was added to the record history, replacing the previous 'Revision: v3.6.5'. This reflects a minor update to the page's underlying software version rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-08-29T22:00:35.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry (v3.6.5) replacing the previous (v3.6.4) to reflect the latest submission. This is a metadata update that does not change the study data or public content.
    Difference
    0.1%
    Check dated 2026-08-08T22:32:12.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry (v3.6.4) as the latest version, and the previous entry (v3.6.3) is removed from the current history view.
    Difference
    0.1%
    Check dated 2026-07-25T12:53:06.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the study record history, replacing the previous v3.6.2. This indicates a routine update to the page's revision tracking or rendering.
    Difference
    0.1%
    Check dated 2026-07-04T03:58:55.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.